Definition
Sorm and Vesely first described the pyrimidine analogs 5-aza-2′-deoxycytidine and 5-azacytidine in the mid-1960. They were generally considered to be in the antimetabolite class of anticancer agents; however, unique actions of 5-aza-2′-deoxycytidine clearly extend these molecules beyond the realm of most other antimetabolites. 5-Aza-2′-deoxycytidine and 5-azacytidine may be better considered as the prototypical agents of an emergent class of therapeutic agents, epigenetic modifiers (epigenetics, epigenetic therapy). The most notable epigenetic effect of these 5-aza-pyrimidines is their ability to demethylate the DNA of proliferating cells, and these drugs are now classified as DNA demethylating agents (methylation). To attain therapeutic efficacy, enzymatic activation of...
References
Christman JK (2002) 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483–5495
Jones PA (1985) Altering gene expression with 5-azacytidine. Cell 40(3):485–486
Jones PA, Bay SB (2007) The epigenomics of cancer. Cell 128:683–912
Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428
Silverman LR, Mufti GJ (2005) Methylation inhibitor therapy in the treatment of myelodysplastic syndrome. Nat Clin Pract Oncol 2(Suppl 1):S12–S23
See Also
(2012) Hypomethylation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1791. doi: 10.1007/978-3-642-16483-5_2922
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Futscher, B.W. (2014). 5-aza-2′ Deoxycytidine. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_503-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_503-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences